Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00265928
Status:
TERMINATED
Last Update Posted:
2008-01-28
First Post:
2005-12-14
Brief Title:
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma
Sponsor:
University of Virginia
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000459747
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Virginia
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |